Nasdaq

Lilly expands insulin affordability options with lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen®

INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...
FiercePharma

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®

INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...
Pharmabiz

US FDA approves updated label for Lilly's Humalog

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) approved the company's supplemental New Drug Application (sNDA) with the following updates to the Humalog label: ...
Nasdaq

Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities

INDIANAPOLIS, Jan. 28, 2020 /PRNewswire/ -- Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and ...
FiercePharma

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...